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Background
The Route Map for Adrenoleukodystrophy (ALD) and
Adrenomyeloneuropathy (AMN) is a user led research
project to create a repository of information and knowl-
edge about two specific rare diseases. This Route Map
provides a comprehensive resource to be used by patients,
families and health and social care professionals.
From our survey we know that more that 60% of our
patients with ALD or AMN are not receiving enough
information and often the information they receive is not
in an easy and patient friendly language. We also know
that this situation is quite common among rare diseases.
The aims and the approach
The aims of the Route Map (RM) have been:
• Improving the quality of care for patients with ALD
and AMN
• Empowering patients and their families, expressing
the potential contribution they can give to the NHS
system
• Improving the quality of the relationship between
patients and specialists
• Improving awareness of the conditions
We have developed the RM using a patient centred
approach. This has meant that patients have been involved
since the beginning and in different phases of the project
to co-design the RM. NHS professionals have also been
involved in the design process.
We have talked with patients to develop the question-
naires to make sure that we were asking the right ques-
tions; involved patients in focus groups to discuss openly
and collectively about some general and some more speci-
fic issue; explored things from a different angle starting
from the patient experience perspective of the care they
have received.
This has made possible to derive knowledge and cre-
ate deep understanding of complex processes; starting
from personal stories we have been able to design the
patient’ journey map.
Conclusion
As the final output of the project we have developed an
online practical and cost-effective platform with the
main information about the care for patients with these
conditions [http://www.ald-amn.info].
This platform will improve the access to information
on health and social care services for individuals and
families with rare conditions.
We think the RM will have the potential to play a key
role in personalised care planning for people with these
conditions. Moreover the co-design approach has been a
learning process for both patients and NHS professionals.
Our experience and the things we’ve learned (what
worked and what didn’t work) are the legacy that we
would like to share with everyone that is starting the same
journey.
Published: 22 November 2012
doi:10.1186/1750-1172-7-S2-A40
Cite this article as: Pierri: A route map for the patients journey.
Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A40.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitCorrespondence: info@aldlife.org
ALD Life, London, SE22 0RG, UK
Pierri Orphanet Journal of Rare Diseases 2012, 7(Suppl 2):A40
http://www.ojrd.com/content/7/S2/A40
© 2012 Pierri; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
